Chief Operating Officer
Tzvi Palash joined Protalix in 2010 as its Chief Operating Officer, bringing with him over 25 years of expertise in commercial operations in the healthcare industry. This experience includes planning, construction, and scale-up of manufacturing facilities, product quality assurance (QA) and validation, regulatory compliance, and general production oversight for biotechnology and pharmaceutical plants. Prior to joining Protalix, from 2006 through 2010, Mr. Palash served as a General Manager of Colbar LifeScience Ltd., a biomaterial company focusing on aesthetics, that was sold to Johnson and Johnson. In that position, Mr. Palash served as a member of the Global Aesthetic Management Team at the Consumer Group of Johnson & Johnson. Prior to that, from 2001 through 2006, Mr. Palash served as the Vice President, Operations of ColBar, and he has served in different positions at Teva Pharmaceutical Industries Ltd. Mr. Palash has an M.Sc. in Biochemistry from the Hebrew University and a B.Sc. in Biology from the Tel Aviv University.